Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2000 Sep;53(9):704–708. doi: 10.1136/jcp.53.9.704

Thymidine phosphorylase expression in normal and hyperplastic endometrium

E Sivridis 1, A Giatromanolaki 1, M Koukourakis 1, R Bicknell 1, A Harris 1, K Gatter 1
PMCID: PMC1731246  PMID: 11041061

Abstract

Aims—To investigate the expression of thymidine phosphorylase (TP), a known angiogenic factor for endothelial cells, in normally cycling endometrium and various forms of endometrial hyperplasia.

Methods—TP expression was assessed with the P-GF.44C monoclonal antibody, using the alkaline phosphatase anti-alkaline phosphatase method. Ninety two normal and hyperplastic endometria were studied.

Results—In normal proliferative endometrium, TP is found exclusively in the basal layer and the inner third of the functionalis; expression is cytoplasmic in glandular epithelium and nuclear in stromal cells. It is invariably patchy. This immunohistochemical picture remains almost unaltered during the early and mid secretory phase of the normal menstrual cycle but, most impressively, TP is expressed uniformly in the epithelium of all endometrial glands towards the end of the cycle. At this stage, expression is mixed nuclear/cytoplasmic and there is very little stromal nuclear staining. In simple endometrial hyperplasia, the staining pattern for TP is identical to normal proliferative endometrium, with a distribution that is usually limited to a few rather weakly proliferating glands and to the adjacent periglandular stroma of the deep endometrium. The distribution is more extensive in complex and atypical endometrial hyperplasias, where a mixed nuclear/cytoplasmic pattern usually prevails over the pure cytoplasmic reaction.

Conclusions—TP is expressed consistently in normal and hyperplastic endometrium, suggesting a role in physiological and pathological angiogenesis. In normal endometrium, TP has a definite pattern of distribution, which is dependent on the phase of the menstrual cycle, whereas in all forms of endometrial hyperplasia the enzyme is randomly distributed and lacks an orderly pattern.

Key Words: thymidine phosphorylase • normal endometrium • hyperplastic endometrium

Full Text

The Full Text of this article is available as a PDF (177.4 KB).

graphic file with name 99344.f1.jpg

Open in a new tab

Figure 1 Thymidine phosphorylase (TP) staining patterns in normal endometrium and various forms of endometrial hyperplasia. (A) Early proliferative phase endometrium with TP confined to the basal layer. Expression is weak/cytoplasmic in the glandular epithelium and strong/nuclear in the periglandular stromal cells. It is invariably patchy. (B) Late secretory phase endometrium: TP is expressed uniformly in the epithelium of all endometrial glands. Expression is strong and mixed nuclear/cytoplasmic. There is no stromal reactivity. (C) Simple endometrial hyperplasia: an irregular hyperplastic gland showing cytoplasmic TP reactivity. (D) Complex endometrial hyperplasia: mixed nuclear/cytoplasmic TP expression in the glandular epithelial cells. (E) Atypical endometrial hyperplasia: an area with strong mixed nuclear/cytoplasmic TP staining in the glandular epithelium.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blood C. H., Zetter B. R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta. 1990 Jun 1;1032(1):89–118. doi: 10.1016/0304-419x(90)90014-r. [DOI] [PubMed] [Google Scholar]
  2. Brown N. S., Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J. 1998 Aug 15;334(Pt 1):1–8. doi: 10.1042/bj3340001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cordon-Cardo C., Vlodavsky I., Haimovitz-Friedman A., Hicklin D., Fuks Z. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest. 1990 Dec;63(6):832–840. [PubMed] [Google Scholar]
  4. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175–203. doi: 10.1016/s0065-230x(08)60946-x. [DOI] [PubMed] [Google Scholar]
  5. Fox S. B., Moghaddam A., Westwood M., Turley H., Bicknell R., Gatter K. C., Harris A. L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol. 1995 Jun;176(2):183–190. doi: 10.1002/path.1711760212. [DOI] [PubMed] [Google Scholar]
  6. Giatromanolaki A., Koukourakis M. I., Comley M., Kaklamanis L., Turley H., O'Byrne K., Harris A. L., Gatter K. C. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol. 1997 Feb;181(2):196–199. doi: 10.1002/(SICI)1096-9896(199702)181:2<196::AID-PATH763>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  7. Griffiths L., Dachs G. U., Bicknell R., Harris A. L., Stratford I. J. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res. 1997 Feb 15;57(4):570–572. [PubMed] [Google Scholar]
  8. Griffiths L., Stratford I. J. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy. Br J Cancer. 1997;76(6):689–693. doi: 10.1038/bjc.1997.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Horowitz G. M., Scott R. T., Jr, Drews M. R., Navot D., Hofmann G. E. Immunohistochemical localization of transforming growth factor-alpha in human endometrium, decidua, and trophoblast. J Clin Endocrinol Metab. 1993 Mar;76(3):786–792. doi: 10.1210/jcem.76.3.7680358. [DOI] [PubMed] [Google Scholar]
  10. Kauma S., Matt D., Strom S., Eierman D., Turner T. Interleukin-1 beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta, and placental membranes. Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1430–1437. doi: 10.1016/0002-9378(90)90601-3. [DOI] [PubMed] [Google Scholar]
  11. Koukourakis M. I., Giatromanolaki A., Kakolyris S., O'Byrne K. J., Apostolikas N., Skarlatos J., Gatter K. C., Harris A. L. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival. Br J Cancer. 1998 May;77(10):1696–1703. doi: 10.1038/bjc.1998.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morgan K. G., Wilkinson N., Buckley C. H. Angiogenesis in normal, hyperplastic, and neoplastic endometrium. J Pathol. 1996 Jul;179(3):317–320. doi: 10.1002/(SICI)1096-9896(199607)179:3<317::AID-PATH598>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  13. Norris H. J., Connor M. P., Kurman R. J. Preinvasive lesions of the endometrium. Clin Obstet Gynaecol. 1986 Dec;13(4):725–738. [PubMed] [Google Scholar]
  14. Polverini P. J., Leibovich S. J. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest. 1984 Dec;51(6):635–642. [PubMed] [Google Scholar]
  15. Rusnati M., Casarotti G., Pecorelli S., Ragnotti G., Presta M. Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. Growth Factors. 1990;3(4):299–307. doi: 10.3109/08977199009003672. [DOI] [PubMed] [Google Scholar]
  16. Sivridis E., Buckley C. H., Fox H. An immunohistochemical study of steroid binding by endometrial glandular epithelial cells throughout the menstrual cycle. Br J Obstet Gynaecol. 1987 Jul;94(7):687–691. doi: 10.1111/j.1471-0528.1987.tb03176.x. [DOI] [PubMed] [Google Scholar]
  17. Sivridis E., Giatromanolaki A., Koukourakis M. I., Bicknell R., Harris A. L., Gatter K. C. Thymidine phosphorylase expression in endometrial carcinomas. Clin Exp Metastasis. 1999 Jul;17(5):445–450. doi: 10.1023/a:1006603709248. [DOI] [PubMed] [Google Scholar]
  18. Stevenson D. P., Milligan S. R., Collins W. P. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am J Pathol. 1998 Jun;152(6):1641–1646. [PMC free article] [PubMed] [Google Scholar]
  19. Zhang L., Mackenzie I. Z., Rees M. C., Bicknell R. Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology. 1997 Nov;138(11):4921–4930. doi: 10.1210/endo.138.11.5517. [DOI] [PubMed] [Google Scholar]
  20. Zhang L., Scott P. A., Turley H., Leek R., Lewis C. E., Gatter K. C., Harris A. L., Mackenzie I. Z., Rees M. C., Bicknell R. Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Pathol. 1998 Aug;185(4):402–408. doi: 10.1002/(SICI)1096-9896(199808)185:4<402::AID-PATH112>3.0.CO;2-Y. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES